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Abstract
Background: Besides the growing acknowledgment of the relevance of posttraumatic stress disorder (PTSD) related to medical illness, there is no study in 
cystic fibrosis yet. Objective: To assess the prevalence of PTSD and the three clusters of posttraumatic stress symptoms (PTSS) in parents of patients with cystic 
fibrosis. Methods: Parents of patients with cystic fibrosis (age range: 2 to 33 years) were drawn from the Cystic Fibrosis Association of the city of Rio de Janeiro. 
In this cross-sectional study, parents were asked to fulfill a questionnaire for social and demographic characteristics and were interviewed by means of the PTSD 
module of the Structured Clinical Interview for DSM-IV. Results: The sample was comprised 62 subjects (46 mothers and 16 fathers). Current prevalence for full 
PTSD was 6.5% and that for partial PTSD was 19.4%. Parents with and without PTSS differed significantly in two psychosocial aspects: the former reported more 
emotional problems (p = 0.001); and acknowledged more often the need for psychological or psychiatric interventions (p = 0.002) than the latter. However, only 
6.3% of the parents with PTSS were in psychological/psychiatric treatment. Discussion: This preliminary study showed that the frequency of PTSD symptoms is 
fairly high among parents of patients with cystic fibrosis, and although these parents recognize they have emotional problems and need psychological/psychiatric 
treatment, their suffering remains “invisible” to the medical system, leading to underdiagnosis and undertreatment. 
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Resumo
Contexto: Apesar do crescente reconhecimento da relevância do transtorno de estresse pós-traumático (TEPT) secundário a doenças médicas, ainda não existem 
estudos em fibrose cística. Objetivo: Verificar a prevalência de TEPT e dos três grupos de sintomas de estresse pós-traumático em pais de pacientes com fibrose 
cística. Métodos: Pais de pacientes com fibrose cística (idade média: 2 a 33 anos) foram recrutados da Associação Carioca de Mucoviscidose. Neste estudo 
transversal, os pais preencheram um questionário sociodemográfico e foram entrevistados por meio do módulo de TEPT do Structured Clinical Interview for 
DSM-IV. Resultados: A amostra era composta de 62 indivíduos (46 mães e 16 pais). A prevalência atual de TEPT foi 6,5% e de TEPT parcial, de 19,4%. Os 
pais com e sem sintomas de TEPT diferiram significativamente em dois aspectos psicossociais: os primeiros relataram mais problemas emocionais (p = 0,001) e 
reconheceram mais frequentemente a necessidade de tratamento psiquiátrico ou psicológico (p = 0,002) que os últimos. Entretanto, somente 6,3% dos pais com 
sintomas de TEPT estavam em tratamento psiquiátrico/psicológico. Conclusões: Este estudo preliminar demonstrou que a frequência dos sintomas de TEPT é 
bem elevada em pais de pacientes com fibrose cística e, apesar de esses pais reconheceram que tem problemas emocionais e precisam de tratamento psiquiátrico/
psicológico, seu sofrimento permanece invisível para o sistema médico, levando ao subdiagnóstico e ao subtratamento. 
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Introduction
Posttraumatic stress disorder (PTSD) is a usually chronic condition 
that is often associated with marked functional impairment and 
decreased quality of life. It is characterized by the presence of three 
symptoms clusters (reexperiencing, avoidance and hyperarousal) that 
occur in response to a traumatic event1. In a Canadian community 
sample, current PTSD prevalence was found to be 2.7% for women 
and 1.2% for men2. Lifetime PTSD prevalence in the general popula-
tion was estimated to be 7.8%3. Existing evidence suggests that partial 
or subclinical PTSD (PTSD symptoms that fall short of meeting full 
criteria) is not only more common than full PTSD in the general 
population but is also accompanied by significant disability2. 
In DSM-III-R, a traumatic event was defined as an occurrence 
outside the range of normal human experience (e.g., war, natural ca-
tastrophes, and rape). In consequence, medical diseases, irrespective 
of their seriousness and consequences, would not qualify as traumatic 
events. Only with the advent of the DSM-IV was the knowledge that 
one’s child has a life-threatening illness recognized as a qualifying 
traumatic event for PTSD. Since then, several studies have demon-
strated that posttraumatic stress symptoms (PTSS) are frequent among 
parents of children with severe diseases4-10. In a recent meta-analysis11, 
the pooled prevalence of PTSD in parents of children with chronic 
medical illnesses (cancer, diabetes mellitus type 1, epilepsy and asthma) 
or undergoing high-risk procedures (bone marrow or solid organ 
transplantation) was estimated in 22.8% (95% CI: 16.4%-29%). 
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The presence of posttraumatic stress symptoms in parents may 
compromise their role as caregivers and can bear serious repercus-
sions for sick children. For example, parents with hypervigilant 
symptoms can overburden health services by requesting frequent 
doctors’ visits or by making an inordinate number of phone calls to 
health personnel12. Furthermore, avoidant symptoms, such as exces-
sive anxiety about doctors’ visits or medical procedures, can lead to 
non-adherence to medical treatment13. 
Cystic fibrosis (CF), a progressive illness that reduces life ex-
pectancy, is the most common lethal autosomal recessive disease 
in Caucasians, with an incidence of 1 in 2,500 births14. It is a major 
cause of pulmonary and gastrointestinal morbidity in children and a 
leading cause of death in early adulthood15. However, the prognosis 
of CF has improved steadily over the last 20 years and the mean life 
expectancy has now reached 30-40 years16. Thus, families have to 
adjust and learn to cope with the stresses of taking care of children 
or adolescents with CF for considerably longer periods. 
Traumatic events could be classified as type 1 trauma (a single 
traumatic event) or type 2 trauma (repeated traumatic events)17. 
Parents of children with CF are exposed to several types of poten-
tially traumatic events during the course of this chronic disease. 
They are likely to be exposed to repeateded threats by witnessing 
their child undergoing painful procedures, recurrent hospitalization, 
and colonization of the airways with antibiotic-resistent bacteria. 
Nowadays, the majority of patients’ deaths are due to respiratory 
failure and one of the greatest potentially traumatic events related 
to CF is lung transplantation. There is growing acknowlegment of 
the traumatic impact of transplantation and postransplant medical 
care on families of patients with CF. Besides the transplant inherent 
risk, the patients and theirs caregivers face the necessity of life-long 
adherence to imunossupressive medication, the development of 
many side effects, and invasive procedures to prevent and manage 
organ rejection18. 
 CF is a chronic and life-threatening medical condition that, be-
sides its dire effects on the patient him/herself, frightens and overbur-
dens the parents, being an important source of traumatic experiences. 
The aim of this study was twofold: 1) to estimate the prevalence of full 
and partial PTSD and of its three symptomatic clusters in a sample 
of parents of patients with CF; and 2) to compare the demographic 
and psychosocial features of parents with and without PTSS, as well 
as the clinical status of their offspring with CF.
Method
Measures
A specifically designed questionnaire was employed to assess 1) the 
socio-demographic characteristics (e.g., marital status, ethnicity, 
family income, educational attainment, and occupation) and 2) the 
mental health status (e.g., history of psychological or psychiatric 
treatment, history of suicide ideation or of suicide attempts) of par-
ents of the patients with CF; and 3) to obtain information regarding 
the medical condition of the patients themselves (e.g., age of the 
patient at the time of the diagnosis, number of hospitalizations during 
the last year, presence of pancreatic insufficiency and colonization/
infection of airway by Pseudomonas aeruginosa, Burkholderia cepacia 
and/or Methicillin resistant Staphylococcus aureus − MRSA).
The PTSD module of the Structured Clinical Interview for 
DSM-IV SCID was used to assess current and lifetime prevalence 
of full and partial PTSD. The SCID is a semi-structured diagnostic 
interview designed for the assessment of mental disorders based 
on DSM criteria. Partial PTSD was defined by the presence of two 
out of the three PTSD symptoms clusters (reexperience, avoid-
ance and arousal) in addition to the A, E and F criteria for PTSD 
(the individual’s response of fear, horror, helpless; duration of the 
disturbance more than 1 month; and the presence of clinically sig-
nificant distress or functioning impairment, respectively). Lifetime 
PTSD was defined as the presence of full PTSD at any time since 
the diagnosis of CF.
Recruitment and assessment of participants
The Cystic Fibrosis Association of the city of Rio de Janeiro, Brazil 
(ACAM) is a local chapter of the Brazilian National Alliance for 
Cystic Fibrosis, and provides assistance to patients with CF and their 
families. The main missions of the local chapters are to increase public 
awareness about CF and to improve the quality of life of those with 
the disease. To be eligible to participate in the study, the parents of 
patients with CF had to be living with them and be responsible for 
their care. Parents with more than one offspring with CF were asked 
to answer all the questions focusing on the patient they worried more 
about. Informed consent was obtained from all participants. The main 
reasons given by parents for not completing the questionnaire were 
lack of time or distress triggered by the questions. 
A psychiatrist with clinical experience in PTSD (MC) and a 
medical student serving her internship in psychiatry (CR) conducted 
the SCID interviews. Both researchers were trained in the SCID 
interview by a senior researcher with extensive experience in the use 
of this instrument (IF). All SCID-PTSD questions were specifically 
directed to the worst moment experienced by the parents regard-
ing the CF since the diagnosis was made. All SCID-PTSD items 
were asked, even when parents failed to endorse the criterion A2; 
this was done in order to provide an estimate of the prevalence of 
each posttraumatic symptom in the whole sample. The protocol of 
the study was submitted and approved by the Institutional Review 
Board of the Institute of Psychiatry of the Universidade Federal do 
Rio de Janeiro and by the executive board of the local chapter of the 
Brazilian National Alliance for Cystic Fibrosis.
Analysis
Parents meeting diagnostic criteria for full current and partial PTSD 
were combined to form the PTSS group. Then, distributions of the 
demographic, psychosocial and clinical condition-related variables 
were calculated for the groups with and without PTSS. Two-sided 
chi-square and Fisher exact tests were used for the categorical and two-
sided Mann-Whitney test for the continuous variables. Significance 
was set up at a p value ≤ 0.05. Data were analyzed using the Statistical 
Package for the Social Sciences for Windows (10.0 SPSS version). 
Results
Participants’ characteristics
The 93 parents of the 165 patients who had attended regularly the 
ACAM from July 2005 to August 2006 were approached by a research 
assistant who explained the goals and methods of the study. Two 
parents were excluded because they were unable to communicate 
effectively with the researchers (one due to a serious hearing loss and 
the other due to a mild mental retardation). Two parents refused to 
participate in the study without any further explanation. The remain-
ing 89 parents were requested to fill out the demographic, psychoso-
cial, and clinical questionnaire. Sixty-seven parents (75.3%) returned 
the questionnaire. Two parents were excluded because they failed to 
fill out most of the questionnaire. Of the 65 parents that answered the 
questionnaire, one father refused to be interviewed with the SCID. 
The SCID could not be administered to two other fathers because of 
logistical problems. The sample was thus comprised of 62 subjects (46 
mothers and 16 fathers). Most of the SCID-PTSD interviews were 
carried out by telephone (69.4%). There were no significant differ-
ence regarding to social and demographic characteristics between 
respondents and non-respondents, except for an excess of fathers in 
the non-response group. 
The parents’ age ranged from 23 to 62 years (mean = 40 years, 
SD = 10 years). Most participants were Caucasians (64.5%), but 15 
(24.2%) were of mixed Caucasian and African-Brazilian ethnicity 
and seven (11.3%) were African-Brazilians. Twenty-one individuals 
(34.4%) had not completed elementary school, twelve (19.7%) had 
only elementary school, 12 (19.7%) had graduated from high school, 
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and 16 (26.2%) had attended college. Forty-nine parents (80.3%) 
were married or lived a stable relationship, seven (11.5%) were single, 
and five (8.2%) were separated, divorced or widowed. Twenty-eight 
parents (45%) reported a monthly family income of less than two 
minimum wages (approximately U$330). 
The majority of parents (88.7%) had only one son or daughter 
with cystic fibrosis (CF). Seven parents (11.3%) had two offspring 
with CF. One mother had two daughters and one son with CF. 
While eight fathers (50%) reported that they were not the primary 
caregiver, only one mother (2.2%) did not consider herself to be the 
main caregiver responsible for the patient with CF. 
Patients with CF characteristics
Out of the 52 patients with CF, 30 were male. Their age varied from 
2 to 33 (mean = 11.4 years, SD = 7.9 years). The majority of patients 
(57.7%) were Caucasians, 18 (34.6%) were of mixed Caucasian and 
African-Brazilian ethnicity and four (7.7%) were African-Brazilians. 
The time elapsed since the diagnosis of CF ranged from 2 months to 22 
years (mean = 7.3 years, SD = 6.0 years). The patient’s age at the time 
of the diagnosis varied from one week to 23 years (mean = 4.3 years, 
SD = 5.9 years). Twenty-eight patients (53.8%) had had at least one 
hospitalization during the last year, with the total lengths of the hospital 
stays ranging from 3 to 130 days (mean = 30 days, SD = 29.2 days). 
PTSS and PTSD prevalence
Table 1 depicts current and lifetime prevalence of full and partial 
PTSD for the 62 parents. Four parents (6.5%) − three mothers 
(6.5%) and one father (6.3%) − met diagnostic criteria for current 
full PTSD. Moreover, 12 parents (19.4%) fulfilled diagnostic criteria 
for partial PTSD and 11 (17.7%) for lifetime PTSD. When parents 
with current full PTSD were combined with those with partial PTSD 
to form the group with PTSS, a “total” prevalence for PTSS of 25.8% 
(16/62) was obtained. 
Table 1. The distribution of PTSD diagnosis in parents of patients with 
cystic fibrosis
Current full 
PTSD
(%)
Partial PTSD
(%)
Current full 
PTSD plus 
partial PTSD
(%)
Lifetime 
PTSD
(%)
Parents  (n = 62) 6.5 (4) 19.4 (12) 25.8 (16) 17.7 (11)
Mothers (n = 46) 6.5 (3) 19.6 (9) 26.1 (12) 19.6 (9)
Fathers (n = 16) 6.3 (1) 18.8 (3) 25 (4) 12.5 (2)
PTSD = posttraumatic stress disorder.
Table 2. Prevalence of PTSD clusters and PTSD symptoms in parents of patients with cystic fibrosis
Total sample
(n = 62)
Total sample
(%)
PTSD 
symptoms 
group (n=16)
PTSD 
symptoms 
group (%)
No PTSD 
symptoms group
(n = 46)
No PTSD 
symptoms 
group
(%)
χ² p value
Criterion B – Reexperience 39 62.9 16 100 23 5 12.72 0.001
Intrusive recollections 24 38.7 12 75 12 26 11.97 0.002
Nightmares 9 14.5 6 37.5 3 6.5 9.18 0.007†
Flashbacks 10 16.1 6 37.5 4 8.7 7.28 0.014†
Psychological distress 28 45.2 11 68.8 17 37 4.84 0.056
Physiological reactivity 19 30.6 11 68.8 8 2.2 14.73 0.000†
Criterion C – Avoidance 7 11.3 5 31.3 2 4.3 8.58 0.010†
Cognitive Avoidance 16 25.8 5 31.3 11 23.9 0.33 0.741†
Behavioral avoidance 3 4.8 2 12.5 1 2.2 2.75 0.161†
Psychogenic amnesia 4 6.5 2 12.5 2 4.3 1.31 0.272†
Diminished of interest 12 19.4 7 43.8 5 10.9 8.22 0.008†
Feeling of detachment 7 11.3 5 31.3 2 4.3 8.58 0.010†
Emotional numbing 4 6.5 2 12.5 2 4.3 1.31 0.272†
Sense of foreshortened future 9 14.5 5 31.3 4 8.7 4.87 0.042†
Criterion D – Arousal 39 62.9 15 93.8 24 52.2 8.79 0.008
Insomnia 23 37 11 68.8 12 26 9.26 0.06
Irritability 22 35.5 11 68.8 11 23.9 10.43 0.003
Difficulty concentrating 17 27.4 10 62.5 7 15.2 13.34 0.001†
Hypervigilance 44 71 14 87.5 30 65.2 2.86 0.117†
Exaggerated startle response 22 35.5 10 62.5 12 26.1 6.88 0.020
PTSD: posttraumatic stress disorder.
† Fisher’s exact test. 
Table 2 displays frequencies and percentages of PTSS clusters 
(reexperience, avoidance and arousal) and of each specific PTSD 
symptom. Reexperience and arousal were the most frequent 
symptoms clusters among the participants: while 39 parents 
(62.9%) met diagnostic criteria for the reexperiencing cluster and 
39 (62.9%) for the arousal cluster, only seven parents (11.3%) met 
diagnostic criteria for avoidance. All parents in the PTSS group 
fulfilled the criterion B (reexperience). With a single exception, 
all parents with partial PTSD (11/12) failed to fulfill the criterion 
C (avoidance). Hypervigilance was the most frequently reported 
symptom in the whole sample (71%) and in parents with PTSS 
(87.5%). Behavioral avoidance was the less frequently reported 
symptom among all participants (4.8%) and also among the parents 
with PTSS (12.5%). 
As shown in table 3, parents with and without PTSS differed sig-
nificantly in two psychosocial aspects: the former reported emotional 
problems (p = 0.001) and acknowledged they needed psychological 
or psychiatric treatment (p = 0.002) more often than the latter. Re-
garding the clinical condition of the patient, the time elapsed since 
the diagnosis of CF was significantly smaller in the group with PTSS 
than in the group without PTSS (p = 0.05). 
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Table 3. Comparison of parents with and without PTSD symptoms regarding 
their psychosocial-demographic features
Total 
sample
(N = 62)
PTSD 
symptoms 
group
(n = 16)
No PTSD 
symptoms 
group
(n = 46)
p 
Age in years, mean (SD) 40 (10) 39.9 (9.7) 40.8 (10) 0.652 
n (%) n (%) n (%) p
Female 46 (74.2) 12 (75) 34 (73.9) NS†
Educational level higher than 
elementary school
37 (60.7) 8 (50) 29 (64.4) NS
Married or lived a stable 
relationship
49 (79) 14 (87.5) 35 (77.8) NS†
Family income lower than 2 
minimum salaries
28 (45) 9 (60) 19 (41.3) NS
More than one offspring with CF 8 (12.9) 2 (12.5) 6 (13) NS†
Primary caregiver 53 (85.5) 15 (93.8) 38 (82.6) NS
Referred emotional problems 30 (48.4) 14 (87.5) 16 (36.4) 0.001
Psychological/psychiatric treatment 13 (21) 1 (6.3) 12 (26.7) NS†
Use of psychotropic 13 (21) 3 (18.8) 10 (22.2) NS†
Needs of psychological or 
psychiatric treatment
24 (38.7) 12 (80) 12 (30) 0.002
Ideas of suicide 10 (16.1) 4 (25) 6 (13.6) NS†
Plans of suicide 4 (6.5) 2 (12.5) 2 (4.5) NS†
Suicide attempts 4 (6.5) 1 (6.3) 3 (6.8) NS†
PTSD: posttraumatic stress disorder.
† Fisher’s exact test. 
Table 4. Comparison of parents with and without PTSD symptoms regarding 
the clinical features of patients with CF
Patients 
with CF
PTSD 
symptoms 
group
No PTSD 
symptoms 
group
p 
value
Age in years, mean (SD) 11.4 (7.9) 9.4 (7.4) 12.2 (8.1) 0.265
Female, n (%) 22 (35.5) 7 (46.7) 15 (40.5) 0.924
Time since diagnosis of CF in 
years, mean (SD)
7.3 (6.0) 4.7 (4.3) 8.3 (6.4) 0.049
Age at the time of diagnosis of 
CF in years, mean (SD)
4.3 (5.9) 4.7 (6.4) 4.2 (5.7) 0.558 
Had hospitalized in the last year, 
n (%)
28 (45.2) 9 (60) 19 (52.8) 0.870
Days hospitalized in the last year, 
mean (SD), n = 25/52
30 (29.2) 45.25 (41.8) 22.9 (18.5) 0.111
Pancreatic insufficiency, n (%) 40 (64.5) 12 (85.7) 28 (84.8) 1.000†
Pseudomonas aeruginosa, n (%) 24 (38.7) 6 (42.9) 18 (58.1) 0.533
Burkholderia cepacia, n (%) 4 (6.5) 1 (8.3) 3 (10.7) 1.000†
MRSA, n (%) 4 (6.5) 2 (15.4) 2 (6.5) 0.570†
PTSD: posttraumatic stress disorder; CF: cystic fibrosis; MRSA: Methicillin resistant 
Staphylococcus aureus.
† Fisher’s exact test.
Discussion
To the best of our knowledge, this is the first study to investigate the 
prevalence of PTSD in parents of patients with cystic fibrosis (CF). 
In our sample, current prevalence for full and for partial PTSD were 
6.5% and 19.4%, respectively. The figure for full PTSD was higher 
than that found in the Canadian general population (2.7% in women 
and 2.1% in men)2. However, it was lower than the pooled prevalence 
found by our group for the only six studies4,5,8,9,10,19 that have assessed 
PTSD prevalence in parents of children with other chronic diseases 
or undergoing high-risk procedures (15.1%, 95% CI: 9.5%-20.6%) 
(unpublished data). The prevalence of current partial PTSD (19.4%) 
in our study was also higher than that found in general population 
(3.4% for women and 0.3% for men)2. The presence of partial PTSD 
is associated with significant functional impairment2 and with sui-
cidal ideation, even after controlling for comorbidities such as major 
depressive disorder20. However, despite the growing acknowledgment 
of relevance of the diagnosis of partial PTSD, only four studies have 
assessed this condition in parents of children with chronic diseases 
or undergoing high-risk procedures7,9,19,21. Two of these studies were 
methodologically comparable to ours since they have also employed 
the SCID as the main instrument to diagnose partial PTSD: our 
figures were comparable to those found in mothers of children with 
cancer (20%)19 but higher than those (7.2%) observed in mothers of 
children submitted to hematopoietic stem cell transplantation9. This 
inconsistency may reflect differences in the nature of the traumatic 
event: while hematopoietic stem cell transplantation could be consid-
ered an acute traumatic event, diseases like cancer and cystic fibrosis 
would be more properly classified as chronic stressors. Furthermore, 
Manne et al.9 have probed the mothers for PTSD only after a relatively 
large period of time had elapsed since the stem cell transplantation 
when, presumably, some of the participants may have already had 
fully recovered from their traumatic experience. 
Terr17 proposed that type 1 trauma (single incident traumatic 
event) results in reexperiencing, avoiding, and increased arousal, 
and that type 2 trauma (chronic or prolonged exposure to trauma) 
results in denial, numbing, dissociation, and rage. Famularo et al.22 
suggested that acute cases tend to exhibit sleep difficulties, physiologic 
hyperarousal, and reexperiencing, whereas chronic cases demonstrate 
more dissociation, restricted affect, sadness, and detachment. How-
ever, reexperiencing and arousal were the most frequent symptoms 
clusters found in the present study. Our findings dovetail with those 
of others studies that have assessed the prevalence of PTSS clusters in 
parents of children with serious medical illnesses5,7,9,23 and reported 
that the avoidance cluster was the less frequently found condition. 
Exceptionally, Libov et al.8 observed that the avoidance cluster was as 
frequent as the arousal cluster in mothers of patients with cancer. 
Several factors may account for the finding that avoidance was 
the less frequently reported symptom cluster in our sample. This 
observation might, for instance, reflect a sample bias operating in 
two possible ways: 1) we may have failed to recruit the parents more 
affected by avoidance symptoms, since they may have been refusing to 
participate in CF-local chapter; and 2) severe avoidance symptoms may 
have predisposed some parents to decline to participate in our study. 
Either way, avoidant behavior by itself might conceivably have lead to 
an underestimation of the prevalence of PTSD in the present study. 
Alternatively, it might be hypothesized that a relatively low 
prevalence of the avoidance cluster reflects the fact that the parents 
in our study could have no effective ways of distancing themselves 
from the “traumatic event”, since the majority of them were entirely 
responsible for the treatment of their children. Therefore, in condi-
tions where avoidance is almost impossible − as is the case of parents 
of patients with chronic illness − reexperience and arousal may be 
the more prevalent symptom clusters. It follows that the diagnosis 
of PTSD in these cases may be less likely to be made, since all three 
clusters must be present to fulfill the DSM-IV criteria for PTSD.
Hypervigilance was the most frequently reported symptom in 
our sample and physiological reactivity was the one that achieved 
the highest statistical significance when parents with and without 
post-traumatic symptoms were compared. Both symptoms hyper-
vigilance and physiological reactivity – may be related to physical 
symptoms. Physiological reactivity is in itself a physical symptom 
and hypervigilance is a symptom of the hyperarousal cluster which 
has been found to be closely associated with physical health in some 
trauma samples24. Significant physical symptoms may predispose 
these parents to seek treatment in primary care settings. 
Mothers of patients with CF experience greater stress and poorer 
adjustment than mothers of healthy children or the general popula-
tion25. A recent meta-analysis11 found that mothers of children with 
chronic diseases had a significantly higher PTSD prevalence than 
fathers. Mothers are usually more affected than fathers, presumably 
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because they are the primary caregiver and get more personally in-
volved in treatment. In our study, mothers and fathers of patients with 
CF were found to have comparable current full PTSD prevalence: 
6.5% and 6.3%, respectively. The difference between our results and 
those of the meta-analysis should be taken with a grain of salt, since 
it may reflect the low statistical power of the present study. 
A noteworthy finding of our study is the largely unmet need for 
treatment of parents with PTSS. Despite most parents with PTSS hav-
ing reported that they thought they had emotional problems (87.5%) 
and that they felt they needed psychological or psychiatric treatment 
(80%), only one of them was receiving mental health assistance at 
the time of the study. Although these parents acknowledged their 
problems, they were underdiagnosed and undertreated. On the other 
hand, it might be hypothesized that these parents have not sought 
treatment for themselves because either they thought their symptoms 
were a normal reaction to the situation they were going through or 
because their personal problems were considered to have a lower 
priority than their children’s disease.
The presence of PTSS in parents may have significant clinical 
implications for patients with CF. The regimen of therapy necessary 
to preserve health in patients with CF is time-consuming, usually 
takes place at home, and may require the involvement of the whole 
family, especially in early childhood. The CF self-care regimen 
typically consists of chest percussion therapy, pancreatic enzyme 
supplementation, antibiotic courses, and multivitamins. Parents 
may feel very little or no self-efficacy regarding their ability to cope 
with the complexity and the vagaries of the treatment of a serious 
chronic medical illness like CF. Parents with reexperiencing or 
arousal symptoms − the two most frequent symptoms clusters in our 
sample − may have their capacity to understand medical guidelines 
or to transmit essential information to the health care team signifi-
cantly impaired (5). Parents with hypervigilance – the most frequent 
symptom reported in our sample − can overburden health services 
by requesting frequent doctors’ visits or by making an inordinate 
number of phone calls to medical services12. Further, the presence 
of avoidance symptoms in parents may lead to non-adherence to 
medical treatment in their children13.
Regarding the clinical characteristics of the patients with CF in 
the present study, the only measures related to CF severity collected 
in this study (e.g; infections with Pseudomonas aeruginosa, Burk-
holderia cepacia and/or Methicillin resistant Staphylococcus aureus 
– MRSA; and pancreatic insufficiency) were not associated with 
the presence of PTSS in the parents. Although this negative finding 
could be ascribed to the low statistical power of the present study, 
it is consistent with observations made by several previous studies. 
In a recent systematic review of posttraumatic stress in childhood 
cancer survivors and their parents, Bruce26 also found that objective 
medical variables concerning treatment and/or illness severity did not 
correlate with PTSD in parents. The scientific literature on pediatric 
medical traumatic stress suggests that the objective characteristics of 
the medical illness (e.g., severity) and of the related treatments (e.g., 
intensity) are not strongly related to the subsequent development of 
symptoms of PTSD27. These findings are in consonance with the well 
established notion in “traumatology” that the subjective perception 
of risk is more important that the “real danger”.
Limitations
Some methodological concerns of the present study need to be ad-
dressed. The sample is small and there was no control group. More-
over, subjects were recruited from a CF-local chapter, and therefore 
are a selected group of parents that might not be representative of 
the larger population of parents of CF patients. Nevertheless, this 
data is worth to be reported as this is a new area in PTSD research. 
Another limitation was that almost 25% of the contacted parents 
did not participate; these parents may have more PTSD symptoms, 
especially avoidance, and this may have also biased our sample. 
Some important indicators of illness severity such as quality of life 
and pulmonary function status were not included. 
Conclusions
This preliminary study was the first to report PTSD prevalence among 
parents of patients with CF. Like parents of patients with others se-
rious medical diseases, those of patients with CF often suffer from 
PTSS. Our findings highlight the importance of identifying parents 
with PTSS − “our invisible patients”, as Manne28 once called them. To 
improve PTSD detection, health care teams should ask parents of pa-
tients with CF what they are their feelings about their emotional health 
and about the need of psychological/psychiatric treatment. Parents 
reporting emotional problems or need of treatment should be referred 
to specialized treatment. Early recognition of PTSS would avert the 
avenue for chronicity. Future studies should investigate if the presence 
of PTSS affects parent’s role as caregivers and whether the treatment 
of these symptoms would improve the management of patients with 
CF, increasing their offspring’s adherence to CF treatment. 
Acknowledgments
We thank the executive board of the ACAM for making this work 
possible. This research was partially supported by Conselho Nacional 
de Desenvolvimento Científico e Tecnológico (CNPq) trough grant 
#420122/2005-2 (Instituto Milênio – Governo Federal do Brasil), 
by Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro 
(Faperj) trough grant 110.988/2008 and by Confederação Nacional 
do Comércio.
Conflict of interest statement: IF has a daughter with cystic 
fibrosis.
References
1.  American Psychiatric Association. Diagnostic and Statistical Manual of 
Mental Disorders − Fourth Edition (DSM-IV). Washington, DC; 1994.
2.  Stein MB, Walker JR, Hazen AL, Forde DR. Full and partial posttrauma-
tic stress disorder: findings from a community survey. Am J Psychiatr. 
1997;154(8):1114-9.
3.  Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic-
Stress-Disorder in the National Comorbidity Survey. Arch Gen Psychiatr. 
1995;52(12):1048-60.
4.  Iseri PK, Ozten E, Aker AT. Posttraumatic stress disorder and major 
depressive disorder is common in parents of children with epilepsy. 
Epilepsy Behav. 2006;8(1):250-5.
5.  Kazak AE, Alderfer M, Rourke MT, Simms S, Streisand R, Grossman JR. 
Posttraumatic stress disorder (PTSD) and posttraumatic stress symptoms 
(PTSS) in families of adolescent childhood cancer survivors. J Pediatr 
Psychol. 2004;29(3):211-9.
6.  Kean EM, Kelsay K, Wamboldt F, Wamboldt MZ. Posttraumatic stress 
in adolescents with asthma and their parents. J Am Acad Child Adolesc 
Psychiatry. 2006;45(1):78-86.
7.  Landolt MA, Vollrath M, Laimbacher J, Gnehm HE, Sennhauser FH. 
Prospective study of posttraumatic stress disorder in parents of chil-
dren with newly diagnosed type 1 diabetes. J Am Acad Child Adolesc 
Psychiatry. 2005;44(7):682-9.
8.  Libov B, Nevid J, Pelcovitz D, Carmony T. Posttraumatic stress symp-
tomatology in mothers of pediatric cancer survivors. Psychol Health. 
2002;17:501-11.
9.  Manne S, DuHamel K, Ostroff J, Parsons S, Martini DR, Williams SE, et 
al. Anxiety, depressive, and posttraumatic stress disorders among mo-
thers of pediatric survivors of hematopoietic stem cell transplantation. 
Pediatrics. 2004;113(6):1700-8.
10.  Pelcovitz D, Goldenberg B, Kaplan S, Weinblatt M, Mandel F, Meyers 
B, et al. Posttraumatic stress disorder in mothers of pediatric cancer 
survivors. Psychosomatics. 1996;37(2):116-26.
11.  Cabizuca M, Marques-Portella C, Mendlowicz M, Coutinho E, Figueira I. 
Posttraumatic stress disorder in parents of children with chronic illnesses: 
a meta-analysis. Health Psychol. 2009;28(3):379-88.
12.  Pelcovitz D, Libov BG, Mandel F, Kaplan S, Weinblatt M, Septimus A. 
Posttraumatic stress disorder and family functioning in adolescent cancer. 
J Trauma Stress. 1998;11(2):205-21.
17Cabizuca M, et al. / Rev Psiq Clín. 2010;37(1):6-11
13.  Stuber ML, Christakis DA, Houskamp B, Kazak AE. Posttrauma symp-
toms in childhood leukemia survivors and their parents. Psychosomatics. 
1996;37(3):254-61.
14.  Orenstein DM, Winnie GB, Altman H. Cystic fibrosis: a 2002 update. J 
Pediatr. 2002;140(2):156-64.
15.  Morgan WJ, Butler SM, Johnson CA, Colin AA, FitzSimmons SC, Geller 
DE, et al. Epidemiologic study of cystic fibrosis: design and implementation 
of a prospective, multicenter, observational study of patients with cystic 
fibrosis in the U.S. and Canada. Pediatr Pulmonol. 1999;28(4):231-41.
16.  Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361(9358):681-9.
17. Terr LC. Childhood traumas: an outline and overview. Am J Psychiatry. 
1991;148:10-20.
18. Farley L, DeMaso D, D’Angelo E, Kinnamon H, Bastardi C, Hill E, et 
al. Parenting stress and parental pos-traumatic stress disorder in fa-
milies after pediatric heart transplantation. J Heart Lung Transplant. 
2007;26:120-6.
19.  Manne SL, Du HK, Gallelli K, Sorgen K, Redd WH. Posttraumatic 
stress disorder among mothers of pediatric cancer survivors: diagnosis, 
comorbidity, and utility of the PTSD checklist as a screening instrument. 
J Pediatr Psychol. 1998;23(6):357-66.
 20. Marshall RD, Olfson M, Hellman F, Blanco C, Guardino M, Struening 
EL. Comorbidity, impairment, and suicidality in subthreshold PTSD. 
Am J Psychiatry. 2001;158(9):1467-73.
21. Glover DA, Poland RE. Urinary cortisol and catecholamines in mothers 
of child cancer survivors with and without PTSD. Psychoneuroendocri-
nology. 2002;27(7):805-19.
22. Famularo R, Fenton T, Kinscherff R, Augustyn M. Psychiatric comor-
bidity in childhood posttraumatic stress disorder. Child Abuse Negl. 
1996;10:953-61.
23.  Landolt MA, Ribi K, Laimbacher J, Vollrath M, Gnehm HE, Sennhauser 
FH. Posttraumatic stress disorder in parents of children with newly 
diagnosed type 1 diabetes. J Pediatr Psychol. 2002;27:647-52. 
24.  Woods SJ, Wineman NM. Trauma, posttraumatic stress disorder symp-
tom clusters, and physical health symptoms in postabused women. Arch 
Psychiatr Nurs. 2004;18(1):26-34.
25.  Foster C, Eiser C, Oades P, Sheldon C, Tripp J, Goldman P, et al. Treatment 
demands and differential treatment of patients with cystic fibrosis and 
their siblings: patient, parent and sibling accounts. Child Care Health 
Dev. 2001;27(4):349-64.
26.  Bruce M. A systematic and conceptual review of posttraumatic stress 
in childhood cancer survivors and their parents. Clin Psychol Rev. 
2006;26(3):233-56.
27. Kazak A, Kassam-Adams N, Schneider S, Zelikovsky N, Aldefer M, Rourke 
M. An integrative model of pediatric medical traumatic stress. J Pediatr 
Psychol. 2006;31:343-55.
28.  Manne S. Our invisible patients. J Clin Oncol. 2005;23(30):7375-7.
